According to Imunon's latest financial reports the company has a price-to-book ratio of 1.21.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Year | P/B ratio | Change |
---|---|---|
2024-12-31 | N/A | -100% |
2023-12-31 | 0.4774 | 39.51% |
2022-12-31 | 0.3422 | -59.15% |
2021-12-31 | 0.8377 | -46.12% |
2020-12-31 | 1.55 | -43.07% |
2019-12-31 | 2.73 | 114.6% |
2018-12-31 | 1.27 | -21.04% |
2017-12-31 | 1.61 | 36.8% |
2016-12-31 | 1.18 | -46.35% |
2015-12-31 | 2.20 | 54.83% |
2014-12-31 | 1.42 | -15.51% |
2013-12-31 | 1.68 | -93.43% |
2012-12-31 | 25.5 | 1374.45% |
2011-12-31 | 1.73 | -129% |
2010-12-31 | -5.97 | -251.06% |
2009-12-31 | 3.95 | 249.31% |
2008-12-31 | 1.13 | 15.39% |
2007-12-31 | 0.9810 | -115.39% |
2006-12-31 | -6.37 | -150.26% |
2005-12-31 | 12.7 | 65.7% |
2004-12-31 | 7.65 | -46.9% |
2003-12-31 | 14.4 | -58.15% |
2002-12-31 | 34.4 |